This review critically examines the current evidence supporting the clinical utility of germline WES in Hereditary Cancer syndromes, focusing on the clinical scenarios in which WES may provide meaningful additional information beyond multigene panels, its diagnostic yield, limitations, and future perspectives in precis...
Anastasia Dell'Elice, L. Lombardi, Federico Anaclerio et al.· Genes· 0 citations
CES may provide additional exploratory genomic information in selected high-risk BRCA1/2-negative patients, particularly when standard panel testing is uninformative, and represents a valuable resource for future reinterpretation as gene-disease evidence evolves.
Anastasia Dell'Elice, Claudia Palmarini, Federico Anaclerio et al.· Journal of Medical Genetics· 0 citations
RvD5 reduced PD-1 expression on T cells and PD-L1 expression on cancer cells, thereby restoring T cell antitumor functions by delaying their differentiation into Tex, and suppresses tumor growth by dampening inflammation and delaying T cell exhaustion within the TME.
Maria Tredicine, Simona D'Orazio, Nunzia Coletta et al.· Journal of Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.